219 related articles for article (PubMed ID: 15993231)
21. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update.
Sheikh A; Hurwitz B
Br J Gen Pract; 2005 Dec; 55(521):962-4. PubMed ID: 16378567
[TBL] [Abstract][Full Text] [Related]
22. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Jackson WB; Low DE; Dattani D; Whitsitt PF; Leeder RG; MacDougall R
Can J Ophthalmol; 2002 Jun; 37(4):228-37; discussion 237. PubMed ID: 12095096
[TBL] [Abstract][Full Text] [Related]
23. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
[TBL] [Abstract][Full Text] [Related]
24. A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Hwang DG; Schanzlin DJ; Rotberg MH; Foulks G; Raizman MB;
Br J Ophthalmol; 2003 Aug; 87(8):1004-9. PubMed ID: 12881345
[TBL] [Abstract][Full Text] [Related]
25. Chloramphenicol Eye Drops: An Old Dog in a New House.
Andaluz-Scher L; Medow NB
Ophthalmology; 2020 Oct; 127(10):1289-1291. PubMed ID: 32739192
[No Abstract] [Full Text] [Related]
26. The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial.
Rietveld RP; ter Riet G; Bindels PJ; Bink D; Sloos JH; van Weert HC
Br J Gen Pract; 2005 Dec; 55(521):924-30. PubMed ID: 16378561
[TBL] [Abstract][Full Text] [Related]
27. Bacterial conjunctivitis and of antibiotics in Dhulikhel Hospital-Kathmandu University Hospital.
Sthapit PR; Tuladhar NR; Marasini S; Khoju U; Thapa G
Kathmandu Univ Med J (KUMJ); 2011; 9(34):69-72. PubMed ID: 22610873
[TBL] [Abstract][Full Text] [Related]
28. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.
Protzko E; Bowman L; Abelson M; Shapiro A;
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3425-9. PubMed ID: 17652708
[TBL] [Abstract][Full Text] [Related]
29. Topical antibiotics for acute bacterial conjunctivitis: a systematic review.
Sheikh A; Hurwitz B
Br J Gen Pract; 2001 Jun; 51(467):473-7. PubMed ID: 11407054
[TBL] [Abstract][Full Text] [Related]
30. Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.
DeLeon J; Silverstein BE; Allaire C; Gearinger LS; Bateman KM; Morris TW; Comstock TL
Clin Drug Investig; 2012 May; 32(5):303-17. PubMed ID: 22420526
[TBL] [Abstract][Full Text] [Related]
31. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.
Benitez-Del-Castillo J; Verboven Y; Stroman D; Kodjikian L
Clin Drug Investig; 2011; 31(8):543-557. PubMed ID: 21604820
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.
Jauch A; Fsadni M; Gamba G
Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):705-13. PubMed ID: 10447643
[TBL] [Abstract][Full Text] [Related]
33. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.
Denis F; Chaumeil C; Goldschmidt P; Delval L; Pouliquen P; Cochereau I; Chainier D; De Barbeyrac B
Eur J Ophthalmol; 2008; 18(6):858-68. PubMed ID: 18988154
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F;
Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744
[TBL] [Abstract][Full Text] [Related]
35. Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico.
Ramirez-Ortiz MA; Rodriguez-Almaraz M; Ochoa-Diazlopez H; Diaz-Prieto P; Rodriguez-Suárez RS
Br J Ophthalmol; 2007 Nov; 91(11):1430-4. PubMed ID: 17947266
[TBL] [Abstract][Full Text] [Related]
36. Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops.
Dirdal M
Acta Ophthalmol (Copenh); 1987 Apr; 65(2):129-33. PubMed ID: 3300139
[TBL] [Abstract][Full Text] [Related]
37. Do general practitioners adhere to the guideline on infectious conjunctivitis? Results of the Second Dutch National Survey of General Practice.
Rietveld RP; ter Riet G; Bindels PJ; Schellevis FG; van Weert HC
BMC Fam Pract; 2007 Sep; 8():54. PubMed ID: 17868475
[TBL] [Abstract][Full Text] [Related]
38. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis.
Jefferis J; Perera R; Everitt H; van Weert H; Rietveld R; Glasziou P; Rose P
Br J Gen Pract; 2011 Sep; 61(590):e542-8. PubMed ID: 22152728
[TBL] [Abstract][Full Text] [Related]
39. Acute infective conjunctivitis: evidence review and management advice for New Zealand practitioners.
Oliver GF; Wilson GA; Everts RJ
N Z Med J; 2009 Jul; 122(1298):69-75. PubMed ID: 19680306
[TBL] [Abstract][Full Text] [Related]
40. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.
Kernt K; Martinez MA; Bertin D; Stroman D; Cupp G; Martínez C; Tirado M; Guasch J;
Eur J Ophthalmol; 2005; 15(5):541-9. PubMed ID: 16167284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
